REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

UBI Pharma Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: UBI Pharma Inc. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

UBI Pharma Inc. is professional in the development of improved biopharmaceuticals and special injections. The company was founded in 2014 and located in Hsinchu County.

Headquarters
No.45, Guangfu N. Rd., Hukou Township
Hsinchu City; Hsinchu City;

Contact Details: Purchase the UBI Pharma Inc. report to view the information.

Website: http://www.ubi-pharma.com

Basic Information
Total Employees:
Purchase the UBI Pharma Inc. report to view the information.
Outstanding Shares:
Purchase the UBI Pharma Inc. report to view the information.
Financial Auditors:
Purchase the UBI Pharma Inc. report to view the information.
Incorporation Date:
July 31, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
38.1%
Purchase this report to view the information.
0.14%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Ubip Greater China Holding Limited (Hong Kong SAR, China)
100%
Ubip Greater China Second Holding Limited (Hong Kong SAR, China)
100%
Company Performance
Financial values in the chart are available after UBI Pharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
5.24%▲
Total operating revenue
5.24%▲
Operating profit (EBIT)
-5.32%▼
EBITDA
-11.74%▼
Net Profit (Loss) for the Period
-28.45%▼
Total assets
-12.17%▼
Total equity
-7.69%▼
Operating Profit Margin (ROS)
-0.43%▼
Net Profit Margin
-1.94%▼
Return on Equity (ROE)
-0.36%▼
Debt to Equity Ratio
-3.09%▼
Quick Ratio
0.19%▲
Cash Ratio
0.19%▲

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
Pharmally International Holding Co., Ltd
 
Taiwan Biotech Co., Ltd.
Winston Medical Supply Co., Ltd.
 
Maxigen Biotech Inc.
HMD BioMedical Inc.
 
TaiMed Biologics Inc.
SciVision Biotech Inc.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo